Dr. Nisha Acharya, MD

Dr. Acharya practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Acharya's NPI, 1972544872, was assigned on June 10, 2006. Dr. Acharya graduated from UCSF School of Medicine in 2000. Dr. Acharya holds California license A86705.

Dr. Acharya's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Acharya's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Acharya to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Acharya practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Acharya's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Acharya is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Acharya is licensed in California.

Dmand AI lists inflammation of iris and retinal occlusion among the conditions Dr. Acharya treats.

CMS data shows 69 Medicare services from Dr. Acharya across 2 procedure codes in 2024, for 41 Medicare patients. Medicare paid $5,449 for them. Every service was in an office.

CMS counts 41 Medicare patients who saw Dr. Acharya in 2024. The largest group is 65 to 74, with 23 patients. 63% of them have high blood pressure, and 54% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Acharya's median patient age at 49, with 73% women.

In 2019, Dr. Acharya wrote 16 Medicare Part D claims. They cover 1 drug, with $3,108 in total drug cost. In 2016, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Acharya for performance year 2024, reported as part of a group. Dr. Acharya accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 187 papers to Dr. Acharya, published from 2006 to 2025. 2023 was the busiest year, with 13. The most frequent topics are Corneal Ulcer, Visual Acuity and Uveitis. Dr. Acharya has published most often in JAMA Ophthalmol. Dr. Acharya's most frequent co-authors are Thomas M. Lietman, MD, Stephen D. McLeod, MD and John Alexander Gonzales, MD.

Dmand AI links Dr. Acharya to 8 clinical trials, 3 of them phase 3 studies. Conditions studied include Uveitis, Eye Infections, Fungal and Corneal Ulcer. University of California, San Francisco sponsors the most, 6.

CMS Open Payments shows 34 general payments to Dr. Acharya from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 95% of the total. Genentech, Inc. paid the most, $43,521. It also lists 7 research payments totaling $6,389 from 2016 to 2025.

Dmand AI lists 2 awards for Dr. Acharya, most recently CMS Stage 1 EHR in 2013.

Dr. Acharya graduated from UCSF School of Medicine in 2000. Dr. Acharya is a member of AAO.

Dr. Acharya is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.